Thread Content
China’s hydrogen industry is developing new energy and chemical projects in Ordos. Author/Source: Refining & Chemical Industry News. Date: April 20, 2021. Clicks: 10. On the morning of April 16, at the 16th Ordos International Coal and Energy Industry Expo, the people’s government of Dalaat Banner signed agreements with China Hydrogen Energy Co., Ltd. and Ordos Jingchen Technology Co., Ltd. regarding projects related to a clean energy and carbon-neutral industrial chain, as well as projects related to a fine chemicals industry cluster; the total investment for these projects amounts to 17.95 billion yuan. Among them, the Clean Energy and Carbon Neutrality Industrial Chain Project of China Hydrogen Energy Co., Ltd. in Dalaat Banner plans to implement simultaneously a range of projects in this area, including renewable energy power generation, the use of green electricity and hydrogen produced from it to manufacture green ammonia, energy storage and charging services, as well as a platform for new energy logistics trucks. The total investment for these projects is 14.95 billion yuan. The implementation of this project will create an effective closed-loop development cycle for the production, consumption, and utilization of renewable energy, thereby helping Ordos achieve carbon peak and carbon neutrality at an earlier date. Jingchen Technology Co., Ltd. in Ordos plans to build a fine chemicals industry cluster project in the Dalat Economic Development Zone, with a total investment of 3 billion yuan. The first phase involves an investment of 1.1 billion yuan, with an annual production capacity of 14,000 tons of pharmaceutical intermediates such as 2,3-dichloropyridine and isourea. Upon reaching full production in the first phase, annual sales are expected to reach 2 billion yuan, generating profits and taxes of 400 million yuan. Once the project reaches full production capacity, its annual sales will exceed 10 billion yuan, generating profits and taxes of 2 billion yuan. This project falls under the category of pharmaceutical intermediates; its products feature high added value and low energy consumption. By utilizing the world’s most advanced automated control systems and continuous pipeline production lines, it enhances the economic viability and market competitiveness of these products, facilitating their development toward higher precision, higher quality levels, and a position within a higher-value supply chain.